People with HIV may have to take multiple medicines just to keep the virus under control. Medicines for HIV are usually taken every day, and it is crucial that people do not miss their dose or else ...

Cabenuva is administered as two separate injections into the gluteal muscle by a healthcare professional to treat HIV in adults and in children 12 years and older who weigh at least 77 pounds. The ...

Cabenuva, an injectable medication for HIV, may cause both mild and serious side effects. More common side effects include fever, headache, fatigue, nausea, and injection site reactions. Serious but ...

The federal Food and Drug Administration has approved Cabenuva, the first complete long-acting injectable HIV regimen that does not require daily pills. It is approved for people with an undetectable ...

Cabenuva (cabotegravir/rilpivirine) is a prescription drug used to treat HIV in certain adults and children. Cabenuva comes as a liquid suspension (a type of liquid ...

Cabenuva injection is a 2-drug co-packaged product that combines cabotegravir, an HIV integrase strand transfer inhibitor, and rilpivirine, an HIV non-nucleoside reverse transcriptase inhibitor. The ...

The U.S. Food and Drug Administration has approved the first monthly, injectable treatment for HIV. Cabenuva, developed by ViiV Healthcare, replaces the traditional daily pill regimen with two ...

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive findings from the ...